Liontos, M.
Andrikopoulou, A.
Koutsoukos, K.
Markellos, C.
Skafida, E.
Fiste, O.
Kaparelou, M.
Thomakos, N.
Haidopoulos, D.
Rodolakis, A.
Dimopoulos, M. A.
Zagouri, F.
Funding for this research was provided by:
no funding
Article History
Received: 30 June 2021
Accepted: 13 October 2021
First Online: 1 November 2021
Declarations
:
: Informed consent was obtained from all individual participants included in the study. The study has been performed in accordance with the 1964 Helsinki Declaration and has been approved by the Institutional Review Board of Alexandra University Hospital.
: Written informed consent has been obtained from all the patients enrolled to publish this paper.
: Dr. Liontos has received honoraria by Roche, Astra Zeneca, Astellas, MSD, Janssen, BMS and IPSEN, Dr. Koutsoukos has received honoraria by Roche, BMS, MSD and IPSEN, Dr. Zagouri receiving honoraria by Novartis, Eli-Lilly, Merck, Pfizer, and Roche Dr. Dimopoulos has received honoraria by Janssen, Celgene, Takeda, Amgen, Genesis Pharma and BMS.Dr. Andrikopoulou, Dr. Kaparelou, Dr. Markellos, Dr. Fiste, Dr. Skafida, Dr. Thomakos, Dr. Haidopoulos and Dr. Rodolakis declare no conflict of interest.